Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR
- PMID: 20155437
- DOI: 10.1007/s10534-010-9305-5
Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR
Abstract
The lactoferrin gene is known to be expressed either constitutively or under inducible conditions such as hormonal stimuli or inflammation. Its transcription from alternative promoters leads to two products, lactoferrin (Lf) and delta-lactoferrin (DeltaLf) mRNAs the expressions of which are altered during oncogenesis. The comparison of the two enhancer/promoter regions revealed that the two isoforms might be differentially trans-activated. Nevertheless, concomitant expression of both transcripts has been found in some normal tissues and in a subset of breast cancer cell lines and biopsies. Moreover, we found putative inflammatory response elements in both P1 and P2 promoter regions suggesting that both Lf and DeltaLf might be upregulated under inflammatory stimuli. Therefore, a duplex Taqman gene expression assay has been developed and used to profile mRNA expression of the Lf gene in the case of cancer and under inflammatory conditions. Discrimination between the two transcripts is achieved by using a primer pairs/probe set within exon 1beta for DeltaLf and a primer pairs/probe set within exon 1 and exon 2 for Lf. In this study, we confirmed that Lf/DeltaLf Taqman gene expression assay is a powerful tool to investigate the expression of both Lf and DeltaLf transcripts. We also showed that lymphocytes and leukocytes isolated from fresh human blood expressed an extremely high level of DeltaLf messengers. An extensive series of cancer cell lines has been studied confirming that both P1 and P2 promoter regions of the Lf gene are downregulated or silenced in the case of cancer. Furthermore, using stimulation by bacterial lipopolysaccharides (LPS), we showed that in MDA-MB-231 and HT-29 epithelial cells, Lf expression is strongly increased with a higher expression level in MDA-MB-231 whereas DeltaLf expression is not. These results suggest that the NF-kappaB/cRel response elements present in the P1 promoter region are functional whereas those present in the P2 promoter region are not and show that DeltaLf is not regulated in inflammatory conditions.
Similar articles
-
Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer.Int J Cancer. 2005 Mar 20;114(2):299-306. doi: 10.1002/ijc.20728. Int J Cancer. 2005. PMID: 15543612
-
Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme.Biochimie. 2009 Jan;91(1):109-22. doi: 10.1016/j.biochi.2008.07.009. Epub 2008 Aug 7. Biochimie. 2009. PMID: 18725266
-
Characterization of the infection-responsive bovine lactoferrin promoter.Gene. 2005 Jun 20;353(1):107-17. doi: 10.1016/j.gene.2005.04.016. Gene. 2005. PMID: 15935571
-
Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor.Biochem Cell Biol. 2012 Jun;90(3):307-19. doi: 10.1139/o11-070. Epub 2012 Feb 9. Biochem Cell Biol. 2012. PMID: 22320386 Review.
-
Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.J Steroid Biochem Mol Biol. 2005 May;95(1-5):17-23. doi: 10.1016/j.jsbmb.2005.04.002. J Steroid Biochem Mol Biol. 2005. PMID: 15955695 Review.
Cited by
-
SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.PLoS One. 2014 Aug 12;9(8):e104563. doi: 10.1371/journal.pone.0104563. eCollection 2014. PLoS One. 2014. PMID: 25116916 Free PMC article.
-
M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction.Molecules. 2019 Oct 9;24(20):3640. doi: 10.3390/molecules24203640. Molecules. 2019. PMID: 31600968 Free PMC article.
-
Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.Pharmaceuticals (Basel). 2016 Sep 27;9(4):61. doi: 10.3390/ph9040061. Pharmaceuticals (Basel). 2016. PMID: 27690059 Free PMC article. Review.
-
Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin.PLoS One. 2015 Jun 19;10(6):e0129965. doi: 10.1371/journal.pone.0129965. eCollection 2015. PLoS One. 2015. PMID: 26090800 Free PMC article.
-
Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy.Biomolecules. 2022 Jan 12;12(1):119. doi: 10.3390/biom12010119. Biomolecules. 2022. PMID: 35053267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous